SCD-1 inhibitor (Graceway)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSCD-1 inhibitor (Graceway)
Drug Alias NameSCD-1 inhibitor (Pfizer)stearoyl CoA desaturase-1 Inhibitor (Graceway)atearoyl CoA desaturase-1 Inhibitor (Pfizer)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAcyl-CoA desaturase inhibitors
TargetsAcyl-CoA desaturase
Therapy Area/IndicationsSebaceous Gland DiseasesAcne Vulgaris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer IncGraceway Pharmaceuticals Llc
Active IndicationsN/A
Inactive IndicationsSebaceous Gland DiseasesAcne Vulgaris

Other Information

ATC CodeN/A
Related LinksN/A